NCT02019641View on ClinicalTrials.gov

The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 23, 2015

Primary Completion Date

April 2, 2020

Study Completion Date

May 24, 2023

Conditions
Interstitial Lung DiseaseIdiopathic Pulmonary FibrosisInterstitial PneumonitisDesquamative Interstitial Pneumonia
Interventions
OTHER

Aerobic Exercise Training (AET)

walking on a treadmill at vigorous intensity for up to 45 minutes

OTHER

Education

Weekly education

Trial Locations (2)

20892

National Institutes of Health Clinical Center, Bethesda

22042

INOVA Fairfax Hospital, Falls Church

All Listed Sponsors
collaborator

Inova Fairfax Hospital

OTHER

lead

National Institutes of Health Clinical Center (CC)

NIH

NCT02019641 - The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease | Biotech Hunter | Biotech Hunter